BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11549807)

  • 1. Swiss guidelines for the treatment and follow-up of cutaneous melanoma.
    Dummer R; Bösch U; Panizzon R; Bloch PH; Burg G;
    Dermatology; 2001; 203(1):75-80. PubMed ID: 11549807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma.
    Dummer R; Panizzon R; Bloch PH; Burg G;
    Dermatology; 2005; 210(1):39-44. PubMed ID: 15604544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma.
    Dummer R; Guggenheim M; Arnold AW; Braun R; von Moos R;
    Swiss Med Wkly; 2011; 141():w13320. PubMed ID: 22180245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma.
    Dummer R; Siano M; Hunger RE; Lindenblatt N; Braun R; Michielin O; Mihic-Probst D; von Moos R; Najafi Y; Guckenberger M; Arnold A
    Swiss Med Wkly; 2016; 146():w14279. PubMed ID: 26901103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Standards, Options and Recommendations (SOR): clinical practice guidelines for diagnosis, treatment and follow-up of cutaneous melanoma. Fédération Nationale des Centres de Lutte Contre le Cancer].
    Négrier S; Fervers B; Bailly C; Beckendorf V; Cupissol D; Doré JF; Dorval T; Garbay JR; Vilmer C
    Bull Cancer; 2000 Feb; 87(2):173-82. PubMed ID: 10705288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of adult patients with cutaneous melanoma without distant metastasis. 2005 update of the French Standards, Options and Recommendations guidelines. Summary report.
    Saiag P; Bosquet L; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dréno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Négrier S;
    Eur J Dermatol; 2007; 17(4):325-31. PubMed ID: 17540641
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology.
    Bichakjian CK; Halpern AC; Johnson TM; Foote Hood A; Grichnik JM; Swetter SM; Tsao H; Barbosa VH; Chuang TY; Duvic M; Ho VC; Sober AJ; Beutner KR; Bhushan R; Smith Begolka W;
    J Am Acad Dermatol; 2011 Nov; 65(5):1032-47. PubMed ID: 21868127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AJCC melanoma staging update: impact on dermatopathology practice and patient management.
    Piris A; Mihm MC; Duncan LM
    J Cutan Pathol; 2011 May; 38(5):394-400. PubMed ID: 21385199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current guidelines in melanoma treatment. Melanoma Working Group of Gent and Bordet.
    Brochez L; Verhaeghe E; Sales F; Del Marmol V; Deraemaecker R; Vossaert K; Naeyaert JM
    Dermatology; 2000; 200(2):160-6. PubMed ID: 10773711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Stage I cutaneous melanoma.
    Berdeaux DH; Moon TE; Meyskens FL
    Ariz Med; 1983 Nov; 40(11):768-72. PubMed ID: 6661064
    [No Abstract]   [Full Text] [Related]  

  • 11. Patients highly value routine follow-up of skin cancer and cutaneous melanoma.
    Themstrup L; Jemec GE; Lock-Andersen J
    Dan Med J; 2013 Oct; 60(10):A4713. PubMed ID: 24083527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Update on current care guidelines: melanoma].
    Duodecim; 2012; 128(9):988-9. PubMed ID: 22667053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing trends in melanoma treatment and the expanding role of the dermatologist.
    Brown MD; Johnson TM; Swanson NA
    Dermatol Clin; 1991 Oct; 9(4):657-67. PubMed ID: 1934641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of melanoma patients: benefit of intense follow-up schedule is not demonstrated.
    Autier P; Coebergh JW; Boniol M; Dore JF; de Vries E; Eggermont AM
    J Clin Oncol; 2003 Oct; 21(19):3707; author reply 3707-8. PubMed ID: 14512409
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic trends in cutaneous melanoma.
    Hall PN; Javaid M; de Takats PG
    Hosp Med; 1999 Jan; 60(1):39-43. PubMed ID: 10197097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are there special therapeutic methods recommended by some physicians for the management of stage I melanoma?].
    Revuz J
    Ann Dermatol Venereol; 1995; 122(5):319-20. PubMed ID: 8572474
    [No Abstract]   [Full Text] [Related]  

  • 17. [Regression of over 150 skin metastases of malignant melanoma with complex homeopathic therapy].
    Ehring F
    Hautarzt; 1989 Jan; 40(1):23-7. PubMed ID: 2921115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Melanoma malignancy].
    Tilgen W
    Hautarzt; 2008 Jun; 59(6):467-8. PubMed ID: 18463839
    [No Abstract]   [Full Text] [Related]  

  • 19. [Melanoma, from diagnosis to treatment].
    Baroudjian B; Pagès C; Lebbé C
    Rev Infirm; 2016 Mar; (219):16-8. PubMed ID: 26944639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous melanoma: how to improve the quality of diagnosis and treatment - a regional experience.
    Chokoeva AA; Tchernev G; Wollina U; Lotti T
    Dermatol Ther; 2015; 28(6):344-5. PubMed ID: 26279288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.